AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimigoal-MP2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Metcure Remedies Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimigoal-MP2 Tablet ER

Metformin-pioglitazone extended-release tablets manage blood glucose in adults with type 2 diabetes. This dual-action medication complements diet and exercise to enhance glycemic control. It improves insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and schedule; take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals raises the hypoglycemia risk; monitor blood sugar diligently. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose kidney, liver, or heart conditions before initiating treatment. Pregnant or lactating individuals should consult their doctor. Kidney function will be assessed prior to treatment commencement. Limit alcohol consumption to mitigate potential side effects.

Uses of Glimigoal-MP2 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimigoal-MP2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimigoal-MP2 Tablet ER. This extended-release tablet should be swallowed whole with a meal; do not crush, chew, or break it.

Common Side effects of Glimigoal-MP2 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimigoal-MP2 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Glimigoal-MP2 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Glimigoal-MP2 Tablet ER works:

Glimigoal-MP2 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimigoal-MP2 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimigoal-MP2 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glimigoal-MP2 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimigoal-MP2 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimigoal-MP2 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.

LiverLiverCAUTION

Patients with liver impairment should use Glimigoal-MP2 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimigoal-MP2 Tablet ER is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimigoal-MP2 Tablet ER :

Should you forget a Glimigoal-MP2 Tablet ER dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimigoal-MP2 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimigoal-MP2 Tablet ER

Consuming alcohol while taking Glimigoal-MP2 Tablet ER is unsafe. Alcohol can lead to dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Tell your doctor before taking Glimigoal-MP2 Tablet ER if you have congestive heart failure, kidney or liver problems, or swelling behind your eye. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and if you're taking any medications—prescription or over-the-counter—vitamins, or herbal supplements.
Metformin, a component of Glimigoal-MP2 Tablet ER, can lead to vitamin B12 deficiency with prolonged use due to impaired stomach absorption.
Glimigoal-MP2 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as candy or chocolate.
Store this medication in its original, tightly sealed container, following the storage instructions on the packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Glimigoal-MP2 Tablet ER
92
MRP 112
17% off